RecruitingNot ApplicableNCT07424365

Study to Investigate Vagus Nerve Stimulation to Augment Executive Function in Healthy and Cognitively Impaired Populations

Investigation of Vagus Nerve Stimulation to Augment Executive Functioning


Sponsor

University of Colorado, Denver

Enrollment

80 participants

Start Date

May 19, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

This study plans to learn more about how stimulating the vagus nerve through gentle electrical stimulation applied to the ear can affect decision-making, problem-solving, and other thinking abilities. This process, called transcutaneous auricular vagus nerve stimulation (taVNS), could help improve brain function in both healthy individuals and people with Parkinson's disease (PD).


Eligibility

Min Age: 18 YearsMax Age: 65 Years

Inclusion Criteria4

  • Individuals aged 18-65.
  • Ability to sign informed consent.
  • Ability to follow written and verbal instructions.
  • For the PD group, a clinical diagnosis of Parkinson's disease without severe motor or cognitive impairments.

Exclusion Criteria5

  • Current uncontrolled and/or clinically significant medical condition.
  • Abnormal ear anatomy or active ear infection.
  • Electronic medical implants, such as pacemakers, cochlear prosthesis, neuro-stimulators.
  • Uncorrected visual impairments that would interfere with task performance.
  • (6) Other significant diseases or disorders that might impair study participation.

Interventions

DEVICEtranscutaneous auricular vagus nerve stimulation

Electrical stimulation targeting the auricular branch of the vagus nerve

DEVICEsham stimulation

Sham stimulation of the outer ear that does not target the vagus nerve


Locations(1)

Clinical Translational Research Center at CU Anschutz

Aurora, Colorado, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07424365


Related Trials